epocrates logo
epocrates logo
epocrates logo
  • 0

Diseases

Evaluation of primary amenorrhea

OVERVIEW

  • Summary
  • Urgent Considerations
  • Etiology

DIAGNOSIS

  • Differential Diagnosis
  • Diagnostic Approach

IMAGES

  • Library

REFERENCES

  • Citations
  • Credits

Summary

AAFont SizeShareMore Information
Amenorrhea is the transient or permanent absence of menstrual flow and may be subdivided into primary and secondary presentations, relative to menarche.[1]​
  • Primary amenorrhea: lack of menses by age 15 years in a patient with appropriate development of secondary sexual characteristics, or absent menses by age 13 years and no other pubertal maturation.

  • Secondary amenorrhea: lack of menses in a non-pregnant female for at least 3 cycles of her previous interval, or lack of menses for 6 months in a patient who was previously menstruating. See Evaluation of secondary amenorrhea .

Although overlapping attributes exist between the two groups, the diagnostic approaches vary significantly. The prevalence of primary amenorrhea in the US is <0.1%, compared with 4% for secondary amenorrhea.[2] [3] Even when causes of primary and secondary amenorrhea overlap, the relative likelihoods for these etiologies may differ. For example, polycystic ovary syndrome (PCOS) may cause either primary or secondary amenorrhea, but presents usually as secondary amenorrhea. Many causes of primary amenorrhea are rare in the general population (e.g., Kallman syndrome). Conditions that may seem to be rare events generally may appear more commonly in this subgroup of adolescent girls presenting with primary amenorrhea.
Despite the low prevalence of primary amenorrhea, a prompt and comprehensive assessment by a specialist in reproductive medicine, or a clinician well-versed in adolescent development is warranted, as amenorrhea is often the presenting sign of an underlying reproductive disorder. A delay in diagnosis and treatment may adversely impact the long-term future of such patients. For example:[1] [4] [5] [6] [7] [8] [9]​
  • An adolescent with complete androgen insensitivity requires counseling about the eventual removal of gonads, because these patients carry a 14% to 22% risk of gonadal neoplasms, although malignancy is rare before the age of 20 years.​ Removal needs to be weighed up against preserving hormone function during puberty and considerations of any fertility potential.​​​​​​

  • Premature ovarian insufficiency occurring at an early age affects bone density during a critical period for bone development.

  • In young teens presenting with PCOS, obesity, and hyperinsulinemia; behavioral and dietary modifications may prevent subsequent metabolic syndrome.​

content by BMJ Group
Last updated

Library

  • World Health Organization classification of amenorrhea

    World Health Organization classification of amenorrhea

  • Imperforate hymen

    Imperforate hymen

Citations

    Key Articles

    • Practice Committee of the American Society for Reproductive Medicine. Current evaluation of amenorrhea: a committee opinion. Fertil Steril. 2024 Jul;122(1):52-61.[Abstract][Full Text]

    • American College of Obstetricians and Gynecologists' Committee on Practice Bulletins-Gynecology. ACOG Committee Opinion No. 605: primary ovarian insufficiency in adolescents and young women. Obstet Gynecol. 2014 Jul;124(1):193-7.[Abstract][Full Text]

    • Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. J Clin Endocrinol Metab. 2023 Sep 18;108(10):2447-69.[Abstract][Full Text]

    • American College of Obstetricians and Gynecologists' Committee on Adolescent Health Care-Gynecology. ACOG Committee Opinion No. 728: Müllerian agenesis: diagnosis, management, and treatment. Obstet Gynecol. 2018 Jan;131(1):e35-42.[Abstract][Full Text]

    Referenced Articles

    • 1. Practice Committee of the American Society for Reproductive Medicine. Current evaluation of amenorrhea: a committee opinion. Fertil Steril. 2024 Jul;122(1):52-61.[Abstract][Full Text]

    • 2. Timmreck LS, Reindollar RH. Contemporary issues in primary amenorrhea. Obstet Gynecol Clin North Am. 2003;30:287-302.[Abstract]

    • 3. Pettersson F, Fries H, Nillius SJ. Epidemiology of secondary amenorrhea: incidence and prevalence rates. Am J Obstet Gynecol. 1973;117:80-86.[Abstract]

    • 4. Weidler EM, Linnaus ME, Baratz AB, et al. A management protocol for gonad preservation in patients with androgen insensitivity syndrome. J Pediatr Adolesc Gynecol. 2019 Dec;32(6):605-11.[Abstract][Full Text]

    • 5. Tack LJW, Maris E, Looijenga LHJ, et al. Management of gonads in adults with androgen insensitivity: an international survey. Horm Res Paediatr. 2018;90(4):236-46.[Abstract][Full Text]

    • 6. Hughes IA, Davies JD, Bunch TI, et al. Androgen insensitivity syndrome. Lancet. 2012 Oct 20;380(9851):1419-28.[Abstract][Full Text]

    • 7. American College of Obstetricians and Gynecologists' Committee on Practice Bulletins-Gynecology. ACOG Committee Opinion No. 605: primary ovarian insufficiency in adolescents and young women. Obstet Gynecol. 2014 Jul;124(1):193-7.[Abstract][Full Text]

    • 8. Shroff R, Kerchner A, Maifeld M, et al. Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis. J Clin Endocrinol Metab. 2007;92:4609-4614.[Abstract][Full Text]

    • 9. Lass N, Kleber M, Winkel K, et al. Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls. J Clin Endocrinol Metab. 2011 Nov;96(11):3533-40.[Abstract][Full Text]

    • 10. Caronia LM, Martin C, Welt CK, et al. A genetic basis for functional hypothalamic amenorrhea. N Engl J Med. 2011;364:215-25.[Abstract]

    • 11. Agents stimulating gonadal function in the human. Report of a WHO scientific group. World Health Organ Tech Rep Ser. 1973;514:1-30.[Full Text]

    • 12. Munro MG, Balen AH, Cho S, et al. The FIGO ovulatory disorders classification system. Int J Gynaecol Obstet. 2022 Oct;159(1):1-20.[Abstract][Full Text]

    • 13. Brenner SH, Lessing JB, Quagliarello J, et al. Hyperprolactinemia and associated pituitary prolactinomas. Obstet Gynecol. 1985;65:661-664.[Abstract]

    • 14. Verp MS, Simpson JL. Abnormal sexual differentiation and neoplasia. Cancer Genet Cytogenet. 1987;25:191-218.[Abstract]

    • 15. Herman-Giddens ME, Slora EJ, Wasserman RC, et al. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. Pediatrics. 1997;99:505-12.[Abstract]

    • 16. American College of Obstetricians and Gynecologists. ACOG Committee opinion no. 651: menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Dec 2015 [internet publication].[Full Text]

    • 17. Witchel SF. Puberty and polycystic ovary syndrome. Mol Cell Endocrinol. 2006;254-255:146-153.[Abstract]

    • 18. Garnett MR, Puget S, Grill J, et al. Craniopharyngioma. Orphanet J Rare Dis. 2007 Apr 10;2:18.[Abstract][Full Text]

    • 19. Bhagavath B, Layman LC. The genetics of hypogonadotropic hypogonadism. Semin Reprod Med. 2007;25:272-286.[Abstract]

    • 20. Turner HH. A syndrome of infantilism, congenital webbed neck and cubitus valgus. Endocrinology. 1938;23:566.

    • 21. Jayasena CN, Devine K, Barber K, et al. Society for endocrinology guideline for understanding, diagnosing and treating female hypogonadism. Clin Endocrinol (Oxf). 2024 Nov;101(5):409-42.[Abstract][Full Text]

    • 22. Goodman LR, Warren MP. The female athlete and menstrual function. Curr Opin Obstet Gynecol. 2005;17:466-70.[Abstract]

    • 23. Gordon CM, Ackerman KE, Berga SL, et al. Functional hypothalamic amenorrhea: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2017 May 1;102(5):1413-39.[Abstract][Full Text]

    • 24. ESHRE, ASRM, CREWHIRL and IMS Guideline Group on POI, Panay N, Anderson RA, et al. Evidence-based guideline: premature ovarian insufficiency. Fertil Steril. 2025 Feb;123(2):221-36.[Abstract][Full Text]

    • 25. Krassas GE, Pontikides N, Kaltsas T, et al. Disturbances of menstruation in hypothyroidism. Clin Endocrinol (Oxf). 1999;50:655-659.[Abstract]

    • 26. Groff TR, Shulkin BL, Utiger RD, et al. Amenorrhea-galactorrhea, hyperprolactinemia, and suprasellar pituitary enlargement as presenting features of primary hypothyroidism. Obstet Gynecol. 1984;63(3 Suppl):86S-89S.[Abstract]

    • 27. Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. J Clin Endocrinol Metab. 2023 Sep 18;108(10):2447-69.[Abstract][Full Text]

    • 28. Elhassan YS, Hawley JM, Cussen L, et al. Society for Endocrinology clinical practice guideline for the evaluation of androgen excess in women. Clin Endocrinol (Oxf). 2025 Oct;103(4):540-66.[Abstract][Full Text]

    • 29. Govindarajan M, Rajan RS, Kalyanpur A, et al. Magnetic resonance imaging diagnosis of Mayer-Rokitansky-Kuster-Hauser syndrome. J Hum Reprod Sci. 2008;1:83-85.[Abstract][Full Text]

    • 30. American College of Obstetricians and Gynecologists' Committee on Adolescent Health Care-Gynecology. ACOG Committee Opinion No. 728: Müllerian agenesis: diagnosis, management, and treatment. Obstet Gynecol. 2018 Jan;131(1):e35-42.[Abstract][Full Text]

    • 31. Gibney J, Smith TP, McKenna TJ. The impact on clinical practice of routine screening for macroprolactin. J Clin Endocrinol Metab. 2005 Jul;90(7):3927-32.[Abstract][Full Text]

    • 32. Ehrmann DA, Barnes RB, Rosenfield RL, et al. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care. 1999 Jan;22(1):141-6.[Abstract]

    • 33. Thong EP, Codner E, Laven JSE, et al. Diabetes: a metabolic and reproductive disorder in women. Lancet Diabetes Endocrinol. 2020 Feb;8(2):134-49.[Abstract][Full Text]

Have feedback?
Tell us about your experience
Scroll to Top
epocrates logo

Sign in to access our clinical decision support tools

Sign inCreate Account
Download Epocrates from the App StoreDownload Epocrates from the Play Store
About UsFeaturesBusiness SolutionsHelp & Feedback
© 2026 epocrates, Inc.   Terms of UsePrivacy PolicyEditorial PolicyDo Not Sell or Share My Information